{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:23:04Z","timestamp":1772893384650,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ccm.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T09:35:48Z","timestamp":1358415348000},"page":"99-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrew R.","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Sterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2012.12.005_bib1","series-title":"Principles and practice of oncology","first-page":"1489","article-title":"Benign and malignant mesothelioma, cancer","author":"Antman","year":"1993"},{"key":"10.1016\/j.ccm.2012.12.005_bib2","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.103.4_Supplement.373S","article-title":"Natural history and epidemiology of malignant mesothelioma","volume":"103","author":"Antman","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0025-6196(12)65411-1","article-title":"Malignant mesothelioma of the pleura","volume":"63","author":"Pisani","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ccm.2012.12.005_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2012.12.005_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(95)90462-X","article-title":"Continuing increase in mesothelioma mortality in Britain","volume":"345","author":"Peto","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2012.12.005_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thorax.56.4.250","article-title":"Statement on malignant mesothelioma in the United Kingdom","volume":"56","author":"British Thoracic Society Standards of Care Committee","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2012.12.005_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1378\/chest.116.2.504","article-title":"Advances in the treatment of malignant pleural mesothelioma","volume":"116","author":"Sterman","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1843.2005.00714.x","article-title":"Advances in the diagnosis, evaluation and management of malignant pleural mesothelioma","volume":"10","author":"Sterman","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2012.12.005_bib9","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ccm.2012.12.005_bib10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1378\/chest.06-1757","article-title":"Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach","volume":"132","author":"Haas","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1378\/chest.119.6.1641","article-title":"Use of an implantable pleural catheter for \u201ctrapped lung\u201d syndrome in patients with malignant pleural effusion","volume":"119","author":"Pien","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2012.12.005_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e3182114aa0","article-title":"Indwelling pleural catheter: changing the paradigm of malignant effusion management","volume":"6","author":"Lee","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"22","key":"10.1016\/j.ccm.2012.12.005_bib13","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2012.12.005_bib14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1378\/chest.107.5.1454","article-title":"Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion","volume":"107","author":"Waller","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1378\/chest.123.2.551","article-title":"Surgical treatment of malignant pleural mesothelioma: a review","volume":"123","author":"van Ruth","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)36577-8","article-title":"The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial","volume":"102","author":"Rusch","year":"1991","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2012.12.005_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-5223(19)36578-X","article-title":"Extrapleural pneumonectomy, chemotherapy and radiotherapy in the treatment of diffuse malignant pleural mesothelioma","volume":"102","author":"Sugarbaker","year":"1991","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2012.12.005_bib18","doi-asserted-by":"crossref","first-page":"450S","DOI":"10.1378\/chest.116.suppl_3.450S","article-title":"Pleuropneumonectomy in the treatment of malignant pleural mesothelioma","volume":"116","author":"Grondin","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2012.12.005_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1010-7940(01)00594-2","article-title":"Trimodality management of malignant pleural mesothelioma","volume":"19","author":"Maggi","year":"2001","journal-title":"Eur J CardioThorac Surg"},{"issue":"2","key":"10.1016\/j.ccm.2012.12.005_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.semtcvs.2009.07.005","article-title":"Multimodality management of malignant pleural mesothelioma: introduction","volume":"21","author":"Sugarbaker","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ccm.2012.12.005_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1547-4127(04)00109-4","article-title":"Innovative therapies: intraoperative intracavitary chemotherapy","volume":"14","author":"Chang","year":"2004","journal-title":"Thorac Surg Clin"},{"issue":"2","key":"10.1016\/j.ccm.2012.12.005_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","article-title":"Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study","volume":"138","author":"Tilleman","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2012.12.005_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"B\u00f6l\u00fckbas","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02303746","article-title":"Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0003-4975(02)04474-0","article-title":"A\u00a0phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma","volume":"75","author":"Friedberg","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ccm.2012.12.005_bib27","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.athoracsur.2012.02.009","article-title":"Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma","volume":"93","author":"Friedberg","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.ccm.2012.12.005_bib28","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/JTO.0b013e3182288af9","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma","volume":"6","author":"Lang-Lazdunski","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.ccm.2012.12.005_bib29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/JTO.0b013e31824de2dc","article-title":"Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma","volume":"7","author":"B\u00f6l\u00fckbas","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0360-3016(98)00409-X","article-title":"Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura\u2013a single institution experience with 189 patients","volume":"43","author":"de Graaf-Strukowska","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ccm.2012.12.005_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","article-title":"A\u00a0randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma","volume":"91","author":"Bydder","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0360-3016(02)04151-2","article-title":"Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma","volume":"55","author":"Ahamad","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ccm.2012.12.005_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00130404-200311000-00008","article-title":"Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMTR) to the chest","volume":"9","author":"Ahamad","year":"2003","journal-title":"Cancer J"},{"issue":"3","key":"10.1016\/j.ccm.2012.12.005_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ccm.2012.12.005_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3816\/CLC.2003.n.023","article-title":"Chemotherapy for malignant pleural mesothelioma","volume":"5","author":"Janne","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib37","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.lungcan.2008.09.008","article-title":"Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia","volume":"64","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib39","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","article-title":"Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib40","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/cncr.11405","article-title":"Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study","volume":"97","author":"Favaretto","year":"2003","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.ccm.2012.12.005_bib41","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo inpatients with malignant mesothelioma","volume":"30","author":"Kindler","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ccm.2012.12.005_bib42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.23337","article-title":"Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma","volume":"112","author":"Zucali","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6673-3-34","article-title":"Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study","volume":"3","author":"Xanthopoulos","year":"2008","journal-title":"J\u00a0Occup Med Toxicol"},{"key":"10.1016\/j.ccm.2012.12.005_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2008.04.001","article-title":"The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma","volume":"63","author":"Stebbing","year":"2009","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ccm.2012.12.005_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.lungcan.2011.01.005","article-title":"Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience","volume":"73","author":"Pasello","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2010.12.004","article-title":"Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma","volume":"72","author":"Ceresoli","year":"2011","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ccm.2012.12.005_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.6004\/jnccn.2012.0007","article-title":"Novel therapies in phase II and III trials for malignant pleural mesothelioma","volume":"10","author":"Zauderer","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ccm.2012.12.005_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lungcan.2005.04.010","article-title":"Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial","volume":"50","author":"Mathy","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00280-006-0243-4","article-title":"Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma","volume":"59","author":"Porta","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ccm.2012.12.005_bib50","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ccm.2012.12.005_bib51","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lungcan.2004.10.005","article-title":"Thalidomide in patients with malignant pleural mesothelioma","volume":"48","author":"Baas","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/JTO.0b013e3181ec18db","article-title":"A\u00a0phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307","volume":"5","author":"Dubey","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.99.4.911","article-title":"Treatment of malignant pleural effusions with doxorubicin hydrochloride-containing ply (L-lactic acid) microspheres","volume":"99","author":"Ike","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.12.005_bib55","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.bjc.6601000","article-title":"Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies","volume":"88","author":"Monneuse","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/ASO.2003.03.022","article-title":"Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma","volume":"10","author":"van Ruth","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"5859","key":"10.1016\/j.ccm.2012.12.005_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/bmj.2.5859.178-a","article-title":"Postoperative empyema and survival in lung cancer","volume":"2","author":"Bone","year":"1973","journal-title":"Br Med J"},{"issue":"6148","key":"10.1016\/j.ccm.2012.12.005_bib58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/bmj.2.6148.1329","article-title":"Influence of postoperative empyema on survival after pulmonary resection for bronchogenic carcinoma","volume":"2","author":"Minasian","year":"1978","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.ccm.2012.12.005_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/14017438009109865","article-title":"The relationship between postoperative empyema and long-term survival after pneumonectomy. Results of surgical treatment of bronchogenic carcinoma","volume":"14","author":"Lawaetz","year":"1980","journal-title":"Scand J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ccm.2012.12.005_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00199131","article-title":"Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report","volume":"22","author":"Bakker","year":"1986","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ccm.2012.12.005_bib61","first-page":"195","article-title":"The scientific basis for the immunotherapy of human malignant mesothelioma","volume":"3","author":"Robinson","year":"1993","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2012.12.005_bib62","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3","article-title":"Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a phase II study","volume":"83","author":"Astoul","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib63","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N","article-title":"Intrapleural treatment with recombinant gamma-interferon in early stage malignant mesothelioma","volume":"74","author":"Boutin","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib64","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8","article-title":"Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma","volume":"67","author":"Boutin","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib65","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bjc.1995.501","article-title":"Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study","volume":"72","author":"Goey","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ccm.2012.12.005_bib66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/sonc.2002.30234","article-title":"New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents","volume":"29","author":"Nowak","year":"2002","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.ccm.2012.12.005_bib67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00002371-199809000-00007","article-title":"Intralesional cytokine therapy in cancer: a pilot study of GM-CSF infusion in mesothelioma","volume":"21","author":"Davidson","year":"1998","journal-title":"J\u00a0Immunother"},{"issue":"4","key":"10.1016\/j.ccm.2012.12.005_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1165\/rcmb.2010-0026RT","article-title":"Gene therapy for mesothelioma and lung cancer","volume":"42","author":"Vachani","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2012.12.005_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00002371-199805000-00007","article-title":"Cytokine gene therapy or infusion as treatment for solid human cancer","volume":"21","author":"Robinson","year":"1998","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.ccm.2012.12.005_bib70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1165\/ajrcmb.13.1.7598939","article-title":"Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in\u00a0vivo models of human malignant mesothelioma and lung cancer","volume":"13","author":"Hwang","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2012.12.005_bib71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00000658-199507000-00013","article-title":"Successful treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex-thymidine kinase gene","volume":"222","author":"Smythe","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ccm.2012.12.005_bib72","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1089\/hum.1998.9.7-1083","article-title":"Adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma","volume":"9","author":"Sterman","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ccm.2012.12.005_bib73","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.cgt.7700269","article-title":"A\u00a0pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma","volume":"7","author":"Sterman","year":"2000","journal-title":"Cancer Gene Ther"},{"issue":"20","key":"10.1016\/j.ccm.2012.12.005_bib74","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1158\/1078-0432.CCR-05-0405","article-title":"Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase\/ganciclovir suicide gene therapy","volume":"11","author":"Sterman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ccm.2012.12.005_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1165\/ajrcmb.19.2.3123","article-title":"Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma","volume":"19","author":"Schwarzenberger","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"10.1016\/j.ccm.2012.12.005_bib76","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/cgt.2011.60","article-title":"Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study","volume":"18","author":"Schwarzenberger","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ccm.2012.12.005_bib77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.cgt.7700133","article-title":"Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation","volume":"7","author":"Mukherjee","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ccm.2012.12.005_bib78","first-page":"6201","article-title":"Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy due to induction of systemic immunity","volume":"61","author":"Odaka","year":"2001","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ccm.2012.12.005_bib79","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.JTO.0000263706.23579.35","article-title":"Cytokine gene therapy for malignant pleural mesothelioma","volume":"2","author":"Vachani","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ccm.2012.12.005_bib80","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1158\/1078-0432.CCR-07-0403","article-title":"A\u00a0phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses","volume":"13","author":"Sterman","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ccm.2012.12.005_bib81","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/mt.2009.309","article-title":"A\u00a0phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions","volume":"18","author":"Sterman","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.ccm.2012.12.005_bib82","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.201103-0554CR","article-title":"A\u00a0trial of intrapleural adenoviral-mediated interferon-alpha2b gene transfer for malignant pleural mesothelioma","volume":"184","author":"Sterman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.ccm.2012.12.005_bib83","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1158\/0008-5472.CAN-10-2880","article-title":"Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediated regression of human disseminated tumor","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ccm.2012.12.005_bib84","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/147323000803600614","article-title":"Advanced malignant pleural or peritoneal effusion in patients treated with recombinant adenovirus p53 injection plus cisplatin","volume":"36","author":"Dong","year":"2008","journal-title":"J Int Med Res"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252311200130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252311200130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:48:51Z","timestamp":1759452531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252311200130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S027252311200130X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2012.12.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}